On September 22, 2026, the debtors in the Inspired Healthcare Capital Chapter 11 asked a judge in the Northern District of Texas to approve the sale of roughly 30 seniors housing and skilled nursing communities to 10 separate buyers for a combined $717,035,853. The buyer list reads like a cross-section of the industry: Welltower OP LLC, Sonida Acquisition, AREP HC Fund III Investments, National Healthcare Properties Operating Partnership, Inspired Florida Acquisitions, AG2 Acquisitions, Alliance Capital Partners, PHosh, PO Holdco and Conscious Senior Living Management (AltsWire, September 2026; The SeniorCare Investor / Irving Levin Associates, Ben Swett, September 25, 2026).
Divide the price by the community count and you get about $23.9 million each. Do not use that number. The pool blends assisted living with skilled nursing across multiple states, no portfolio-wide unit or bed count was published, and an auction price is partly a function of how the auction was run. It is an arithmetic average, not a valuation.
The number worth your attention is not the price. It is what three separate parties said was wrong with the paperwork.
Three objections, and only one of them is about money
On September 10, two lenders — HPI Fairmount Lender LP and HPI Delray Lender LP — objected that the process had been run as a series of separate, staggered auctions that chilled bidding, and that the debtors had failed to evaluate a whole-company bid as an alternative to breaking the portfolio into ten pieces (AltsWire, September 2026).
On September 14, the Official Committee of Unsecured Creditors objected over purchase-price allocation procedures, escrow arrangements, and the equity payment arrangements offered by Welltower and National Healthcare Properties.
And on September 14, the DST Investors Committee objected to specific terms inside the asset purchase agreements: expanded material adverse effect provisions, and the elimination of specific-performance remedies. Notably, that committee stated expressly that it does not seek to second-guess the auction results (AltsWire, September 2026).
Read that last one twice. The investors were not arguing the price was too low. They were arguing about who can walk away, and what happens if a buyer does.
The structure nobody prices
Inspired Healthcare Capital syndicated Delaware statutory trust interests. That structure exists for one reason: a DST interest qualifies as replacement property in a 1031 exchange, which lets an individual defer capital gains without personally managing a building. It is the most common way a private investor gets fractional ownership of institutional-grade senior housing.
The mechanics matter when things go wrong. In the standard configuration, the DST entity holds title to the real estate. A separate operating company holds the licence, the residents, the staff and the revenue. Two entities, two balance sheets, one building. In good years that separation is invisible and largely beneficial — it is how the structure stays compliant with the rules that make a DST interest exchangeable in the first place.
In a sponsor bankruptcy, that separation is the whole fight. When a portfolio sells, someone has to decide what share of each sale price is consideration for the dirt and what share is consideration for the operating business. The lenders who objected here framed it as staggered auctions and a missing whole-company bid. The unsecured creditors framed it as allocation procedures and escrow. The DST investors framed it as remedies. These are three angles on the same hole: the sale contracts did not settle how proceeds divide between the entity holding title and the entity running the business.
If you own a DST interest, your claim attaches to one side of that line. You do not control which side the money lands on, and you did not negotiate the asset purchase agreement that decides it.
Why specific performance is the tell
Of the three objections, the elimination of specific-performance remedies is the most technical and the most revealing.
Specific performance is the right to compel a buyer to actually close rather than pay damages and walk. Strip it out, widen the definition of a material adverse effect, and a buyer acquires a cheap option: if the market moves or a survey goes badly between signing and closing, they can re-trade or exit. In a solvent sale that is an ordinary risk allocation. In a bankruptcy sale, where the seller is a debtor with a burn rate and a court calendar, it transfers real leverage to the buyer at exactly the moment the estate has none.
That is a term that costs the investors money without ever appearing as a discount to the headline price. It is invisible in the $717,035,853.
The timeline is its own data point
Inspired filed Chapter 11 on February 2, 2026. The auction was scheduled for August 25 but actually ran from August 20 through September 8. The sale hearing was September 22, with a further session possible September 29 (AltsWire, September 2026).
That is more than seven months from filing to a sale hearing, on a platform that was actively marketed to retail exchange investors. Anyone modelling a DST position should assume that a sponsor-level insolvency freezes their capital for the better part of a year before the question of recovery is even reached — and that during that period they have no ability to sell, no ability to exchange out, and no vote on the terms being negotiated.
This is not a distressed market
It would be easy to read a $717 million bankruptcy auction as a referendum on senior housing. It is not. In the same window, Newmark reported closing over $2.0 billion in investment sales and debt transactions across August and the first half of September 2026, and described it as a record-breaking year for dollar volume (Levin, September 23, 2026).
Capital is transacting. What failed here was a sponsor and a capital structure, not an asset class. That distinction is the useful one: the buildings found ten buyers.
What we would want to see before recommending a DST
The Inspired record gives a short, concrete diligence list that costs nothing to run:
Ask where the proceeds go in a sale. Not whether the sponsor expects to sell — ask, in writing, how a sale price would be allocated between the title-holding trust and the operating company, and who decides.
Ask what happens if the sponsor files. Who controls the trust's decisions, and can the trust's interests be sold separately from the operating company's?
Read the remedies. If a future purchase agreement can eliminate specific performance and widen material adverse effect language without investor consent, the price you are shown is not the price you are guaranteed.
Price the illiquidity honestly. Seven months and counting, with no exit, is the observed case here — not a worst case.
None of that is an argument against DSTs. It is an argument for reading the entity chart before the pro forma. The operating economics of these thirty communities were good enough to attract Welltower and nine other buyers. The investors' problem was never the buildings.
*Figures in this article are drawn from AltsWire's reporting on the Inspired Healthcare Capital auction and objection record, and from The SeniorCare Investor / Irving Levin Associates, September 2026. Per-community averages are computed by Crawford Commercial Group Research from reported totals and are not valuations. Individual community names, locations, unit counts and per-asset allocations were not published in the reporting reviewed.*
Disclaimer: This report is provided for informational purposes only and does not constitute investment advice. Data sourced from Bureau of Reclamation, NIC MAP, American Lung Association, and other public institutional sources. Crawford Commercial Group Real Estate Group. April 2026.